|
|
03-11-2009, 07:21 PM
|
#1
|
Senior Member
Join Date: Jan 2007
Location: UK
Posts: 617
|
No Tykerb in the UK, calling all the UK Her2 people
It is the draft decision from NICE to which an apeal can be made.. Any idea anyone?
http://www.nelm.nhs.uk/en/NeLM-Area/...Determination/
We cannot count on any NGO to help us check the pathetic answer from breakthough (the only BC organisation that is meant to be about science):
http://www.breakthrough.org.uk/who_w...nib_mar09.html
Now I am really fed up with comments about the fact that it is because it is a national health service. FYI most western countries EU and Canada have such a system but have tykerb.. so please do politic somewhere else!!! and do not dilute our debate and take a ride on it!!
Anyhow for all of us concerned if anyone wants to take the lead maybe we should have a petition ? any good advocate amongst us ? (I am more of a research person myself). By the way the final decision is to be taken on 27 March, so we need to hurry.
__________________
35 y/o
June 06: BC stage I
Grade 3; ER/PR neg
Her-2+++; lumpectomies
Aug 06: Stage IV
liver mets: 6 tumours
July 06 to Jan 07: 2*FEC+6*Taxotere; 3*TACE; LITT
March 07- Sept 07: Vaccination trial (phase 2, peptide based) at the UW (Seattle).
Herceptin since 2006
NED til Oct 09
Recurrence Oct 2009: to internal mammary gland since October 2009 missed on Oct and March 2010 scan.. palpable nodes in May 2010 when I realised..
Nov 2011:7 mets to lungs progressing fast failed hercp/tykerb/xeloda combo..
superior vena cava blocked: stent but face remains puffy
April 2012: Teresa Trial, randomised to TDM1
Nov 2012 progressing on TDM1
Dec 2012 blockage of my airways by tumours, obliteration of these blocking tumours breathing better but hoping for more- at mo too many tumours to count in the lungs and nodes.
Dec 2012 Starting new trial S-222611 phase 1b dual egfr her2+ inhibitor.
'Under no circumstances should you lose hope..' Dalai Lama
Last edited by fullofbeans; 03-11-2009 at 07:24 PM..
|
|
|
03-11-2009, 07:32 PM
|
#2
|
Senior Member
Join Date: Jan 2008
Location: "Love never fails."
Posts: 5,808
|
I am bumping up this one so the other Her2 sisters from UK can see it.
__________________
Jackie07
http://www.kevinmd.com/blog/2011/06/doctors-letter-patient-newly-diagnosed-cancer.html
http://www.asco.org/ASCOv2/MultiMedi...=114&trackID=2
NICU 4.4 LB
Erythema Nodosum 85
Life-long Central Neurocytoma 4x5x6.5 cm 23 hrs 62090 semi-coma 10 d PT OT ST 30 d
3 Infertility tmts 99 > 3 u. fibroids > Pills
CN 3 GKRS 52301
IDC 1.2 cm Her2 +++ ER 5% R. Lmptmy SLNB+1 71703 6 FEC 33 R Tamoxifen
Recc IIB 2.5 cm Bi-L Mast 61407 2/9 nds PET
6 TCH Cellulitis - Lymphedema - compression sleeve & glove
H w x 4 MUGA 51 D, J 49 M
Diastasis recti
Tamoxifen B. scan
Irrtbl bowel 1'09
Colonoscopy 313
BRCA1 V1247I
hptc hemangioma
Vertigo
GI - > yogurt
hysterectomy/oophorectomy 011410
Exemestane 25 mg tab 102912 ~ 101016 stopped due to r. hip/l.thigh pain after long walk
DEXA 1/13
1-2016 lesions in liver largest 9mm & 1.3 cm onco. says not cancer.
3-11 Appendectomy - visually O.K., a lot of puss. Final path result - not cancer.
Start Vitamin D3 and Calcium supplement (600mg x2)
10-10 Stopped Exemestane due to r. hip/l.thigh pain OKed by Onco 11-08-2016
7-23-2018 9 mm groundglass nodule within the right lower lobe with indolent behavior. Due to possible adenocarcinoma, Recommend annual surveilence.
7-10-2019 CT to check lung nodule.
1-10-2020 8mm stable nodule on R Lung, two 6mm new ones on L Lung, a possible lymph node involvement in inter fissule.
"I WANT TO BE AN OUTRAGEOUS OLD WOMAN WHO NEVER GETS CALLED AN OLD LADY. I WANT TO GET SHARP EDGED & EARTH COLORED, TILL I FADE AWAY FROM PURE JOY." Irene from Tampa
Advocacy is a passion .. not a pastime - Joe
|
|
|
03-11-2009, 08:27 PM
|
#3
|
Senior Member
Join Date: Jan 2007
Location: Thornhill, Ontario
Canada
Posts: 2,320
|
Full of Beans
I understand that Herceptin got approved in Canada when a Her2+ BC patient went to the press, and basically said that Herceptin was a proven drug and would save her life... this was front page news... and Herceptin was approved shortly after that. Not sure of the official date, but I believe in 2005 sometime.
Perhaps a group of you could call a press conference, maybe get your UK Breast Cancer Foundation involved, some oncs. etc.
Wish I could help more, sending you the best from Canada.
all the best
caya
__________________
ER90%+/PR 50%+/HER 2+
1.7 cm and 1.0 cm.
Stage 1, grade 2, Node Negative (16 nodes tested)
MRM Dec.18/06
3 x FEC, 3 x Taxotere
Herceptin - every 3 weeks for a year, finished May 8/08
Tamoxifen - 2 1/2 years
Femara - Jan. 1, 2010 - July 18, 2012
BRCA1/BRCA2 Negative
Dignosed 10/16/06, age 48 , premenopausal
Mild lymphedema diagnosed June 2009 - breast surgeon and lymph. therapist think it's completely reversible - hope so.
Reclast infusion January 2012
Oopherectomy October 2013
15 Years NED!!
|
|
|
03-11-2009, 09:59 PM
|
#4
|
Senior Member
Join Date: Oct 2005
Posts: 3,519
|
All I can offer is that I am just so very sorry that this is happening.
__________________
Brenda
NOV 2012 - 9 yr anniversary
JULY 2012 - 7 yr anniversary stage IV (of 50...)
Nov'03~ dX stage 2B
Dec'03~ Rt side mastectomy, Her2+, ER/PR+, 10 nodes out, one node positive
Jan'04~ Taxotere/Adria/Cytoxan x 6, NED, no Rads, Tamox. 1 year, Arimadex 3 mo., NED 14 mo.
Sept'05~ micro mets lungs/chest nodes/underarm node, Switched to Aromasin, T/C/H x 7, NED 6 months - Herceptin only
Aug'06~ micro mets chest nodes, & bone spot @ C3 neck, Added Taxol to Herceptin
Feb'07~ Genetic testing, BRCA 1&2 neg
Apr'07~ MRI - two 9mm brain mets & 5 punctates, new left chest met, & small increase of bone spot C3 neck, Stopped Aromasin
May'07~ Started Tykerb/Xeloda, no WBR for now
June'07~ MRI - stable brain mets, no new mets, 9mm spots less enhanced, CA15.3 down 45.5 to 9.3 in 10 wks, Ty/Xel working magic!
Aug'07~ MRI - brain mets shrunk half, NO NEW BRAIN METS!!, TMs stable @ 9.2
Oct'07~ PET/CT & MRI show NED
Apr'08~ scans still show NED in the head, small bone spot on right iliac crest (rear pelvic bone)
Sept'08~ MRI shows activity in brain mets, completed 5 fractions/5 consecutive days of IMRT to zap the pesky buggers
Oct'08~ dropped Xeloda, switched to tri-weekly Herceptin in combo with Tykerb, extend to tri-monthly Zometa infusion
Dec'08~ Brain MRI- 4 spots reduced to punctate size, large spot shrunk by 3mm, CT of torso clear/pelvis spot stable
June'09~ new 3-4mm left cerrebellar spot zapped with IMRT targeted rads
Sept'09~ new 6mm & 1 cm spots in pituitary/optic chiasm area. Rx= 25 days of 3D conformal fractionated targeted IMRT to the tumors.
Oct'09~ 25 days of low dose 3D conformal fractionated targeted IMRT to the bone mets spot on rt. iliac crest that have been watching for 2 years. Added daily Aromasin back into treatment regimen.
Apr'10~ Brain MRI clear! But, see new small spot on adrenal gland. Change from Aromasin back to Tamoxifen.
June'10~ Tumor markers (CA15.3) dropped from 37 to 23 after one month on Tamoxifen. Continue to monitor adrenal gland spot. Remain on Tykerb/Herceptin/Tamoxifen.
Nov'10~ Radiate positive mediastinal node that was pressing on recurrent laryngeal nerve, causing paralyzed larynx and a funny voice.
Jan'11~ MRI shows possible activity or perhaps just scar tissue/necrotic increase on 3 previously treated brain spots and a pituitary spot. 5 days of IMRT on 4 spots.
Feb'11~ Enrolled in T-DM1 EAP in Denver, first treatment March 25, 2011.
Mar'11~ Finally started T-DM1 EAP in Denver at Rocky Mountain Cancer Center/Rose on Mar. 25... hallelujah.
"I would rather be anecdotally alive than statistically dead."
|
|
|
03-11-2009, 10:04 PM
|
#5
|
Senior Member
Join Date: Dec 2005
Location: Walnut Creek, CA
Posts: 438
|
I am sorry, too that this is happening.
Karen
|
|
|
03-11-2009, 10:06 PM
|
#6
|
Senior Member
Join Date: Apr 2008
Posts: 1,477
|
Must all the pressure come from within the UK? What about pressure from oncologists/researchers in other countries viewing Tykerb as an important option?
|
|
|
03-12-2009, 12:53 AM
|
#7
|
Guest
|
Sadly it is likely that the only way for this decision to be changed will be either for some clinical trial to come out which shows this drug to be so effective that it simply cannot be ignored, or someone will have to require the drug on advice from their oncologist and have their local Primary Care Trust (PCT) refuse it and then take them to court (just like Ann Marie Rogers did for Herceptin).
What might just make it a news worthy item in papers and TV is that just about every BC patient here in the UK to write to the TV companies and newspapers to highlight the issue of Tyverb (as it seems to be more commonly called here). Also if every BC patient wrote to their MP it might also just have some effect (although I dont have great hopes for UK MPs doing anything as the percentage of population involved is not big enough to make them fear losing their seats).
If there was a forum like this here in the UK to which the UK BC patients subscribed then there might be a body of opinion which might just be listened to here.
|
|
|
03-12-2009, 09:00 AM
|
#8
|
Senior Member
Join Date: Jan 2007
Location: UK
Posts: 617
|
Well there is something quite illogical in simply saying that more clinical trial results need to be carried out in that:
Are you saying that all the other countries such as France for example are simply making Tykerb available on no scientific background ??
Because if that it to you a satisfactory answer, well I beleive that what was said about Herceptin.. when an independent court reviewed the evidence they found that NICE was wrong.
So the real question that is emerging really is: Is NICE an independent body capable of reviewing scientific evidence??
__________________
35 y/o
June 06: BC stage I
Grade 3; ER/PR neg
Her-2+++; lumpectomies
Aug 06: Stage IV
liver mets: 6 tumours
July 06 to Jan 07: 2*FEC+6*Taxotere; 3*TACE; LITT
March 07- Sept 07: Vaccination trial (phase 2, peptide based) at the UW (Seattle).
Herceptin since 2006
NED til Oct 09
Recurrence Oct 2009: to internal mammary gland since October 2009 missed on Oct and March 2010 scan.. palpable nodes in May 2010 when I realised..
Nov 2011:7 mets to lungs progressing fast failed hercp/tykerb/xeloda combo..
superior vena cava blocked: stent but face remains puffy
April 2012: Teresa Trial, randomised to TDM1
Nov 2012 progressing on TDM1
Dec 2012 blockage of my airways by tumours, obliteration of these blocking tumours breathing better but hoping for more- at mo too many tumours to count in the lungs and nodes.
Dec 2012 Starting new trial S-222611 phase 1b dual egfr her2+ inhibitor.
'Under no circumstances should you lose hope..' Dalai Lama
|
|
|
03-12-2009, 09:23 AM
|
#9
|
Guest
|
Well its not simply clinical trials they work on. They do a kind of calculation based on extended quality of life for a cost benefit case and if that comes out too expensive they wont allow it to be used. This is the problem with NICE in the UK they are cost driven as well which is why the UK have so much trouble getting these new drugs.
|
|
|
03-12-2009, 09:43 AM
|
#10
|
Senior Member
Join Date: Feb 2009
Posts: 1,526
|
Hi ,
I am also outraged that NICE will not approve Tyverb and the pathetic response of the breast cancer charities.
What I have done so far is to contact NICE and lodge a protest against the decision, contacted two MP's and requested they raise this issue with the Minister and thirdly have contacted my trade union branch (Amicus) and put forward a resolution. Not been able to do more as recovering from surgery. A couple of problems are becoming apparent already. Firstly having raised Tyverb with two onc's their response was that they would be reluctant to prescribe as there was not enough 'mature ' data! Of course their prescribing will be governed by NICE so would be out of the question anyway.Secondly the position of the MP's, whilst sympathetic argued that NICE was an independent body appointed by gov so it would be difficult to go against their findings! Personally I believe it is all to do with money particularly now we are officially in recession.
Does anyone know GSK's position about appealing?
Due to see new onc very soon. Been contemplating what action I will take if he tells me that Tyverb could be a drug clinically indicated for me. I believe any court action may not be possible based on prohibitive costs. Any views?
Ellie
|
|
|
03-12-2009, 10:19 AM
|
#11
|
Senior Member
Join Date: Jul 2007
Location: Canada
Posts: 2,193
|
I don't think other countries are basing their decisions on their own
research and clinical trials. When Herceptin was approved in Canada,
I'm sure the data etc. came from the United States. I don't think Canada
did much in the way of clinical trials on that drug.
This sounds like NICE's decision is based on $$$. The information/research/
clinical trials are all out there.
__________________
PinkGirl
Dx Aug/05 at age 51
2cm. Stage 2A, Grade 3
ER+/PR-
Her2 +++
Sept 7/05 Mastectomy
4 FAC, 4 Taxol, no radiation
1 year of Herceptin
Tamoxifen for approx. 4 months,
Arimidex for 5 years
Prophylactic mastectomy June 22/09
" I yam what I yam." - Popeye
My Photo Album
|
|
|
03-12-2009, 10:57 AM
|
#12
|
Senior Member
Join Date: Sep 2005
Location: Central Coast, CA
Posts: 3,207
|
Ellie beat me to this thought...what is GSK doing in response to this?
__________________
Chris in Scotts Valley
June 2002 extensive hi grade DCIS (pre-cancer-stage 0, clean sentinal node) Mastectomy/implant - no chemo, rads. "cured?"
9/2004 Diag: Stage IV extensive liver mets (!) ER/PR- Her2+++
10/04-3/05 Weekly Taxol/Carboplatin/Herceptin , complete response!
04/05 - 4/07 Herception every 3 wks, Continue NED
04/07 - recurrence to liver - 2 spots, starting tykerb/avastin trial
06/07 8/07 10/07 Scans show stable, continue on Tykerb/Avastin
01/08 Progression in liver
02/08 Begin (TDM1) trial
08/08 NED! It's Working! Continue on TDM1
02/09 Continue NED
02/10 Continue NED. 5/10 9/10 Scans NED 10/10 Scans NED
12/10 Scans not clear....4/11 Scans suggest progression 6/11 progression confirmed in liver
07/11 - 11/11 Herceptin/Xeloda -not working:(
12/11 Begin MM302 Phase I trial - bust:(
03/12 3rd times the charm? AKT trial
5/12 Scan shows reduction! 7/12 More reduction!!!!
8/12 Whoops...progression...trying for Perjeta/Herceptin (plus some more nasty chemo!)
9/12 Start Perjeta/Herceptin, chemo on hold due to infection/wound in leg, added on cycle 2 &3
11/12 Poops! progression in liver, Stop Perjeta/Taxo/Herc
11/12 Navelbine/Herce[ptin - try for a 3 cycles, no go.
2/13 Gemzar/Carbo/Herceptin - no go.
3/13 TACE procedure
|
|
|
03-12-2009, 01:03 PM
|
#13
|
Senior Member
Join Date: Jun 2007
Posts: 216
|
Hi all,
Having just come up to 3 years ned early stage breast cancer after having to worry about getting herceptin at the end of my chemo and rads and I found (via the televison) on the 23rd august 2006 that I would get it(five days before I finished rads).
Now basically I see a surgical registrar once a year (not the surgeon who did my mastectomy) I have had to fight for it but I do get yearly mammograms and ovarian scans and definitedly no oncologist and I just wanted to have something to hang on to if needed which was tykerb.
I am so furious
Janie (from the UK). Here we go again in this country ,like we had to do for herceptin!
|
|
|
03-12-2009, 01:22 PM
|
#14
|
Senior Member
Join Date: Feb 2009
Posts: 1,526
|
Hi again,thought I might ask GSK that question tomorrow! Not too hopeful though as last time I rang them about one of their drugs two hours later I was still trying to speak to the right person.
If I get a response I will post it.
Just to have a bit more of a rant it annoyed me even more when at the end of the NICE guidelines they referred to needing more evidence from clinical trials. Clearly they don't think that research from abroad is worth considering-how arrogant
Ellie
|
|
|
03-13-2009, 10:08 AM
|
#15
|
Senior Member
Join Date: Jan 2007
Location: UK
Posts: 617
|
Off course it is about money it always is, but why then do the charities response to it is that they need to carry out more trials?
I agree with Elly it is very arrogant and from the charity point of view a really poor response.
Why do they not simply say that the patients are not worth the money, call a cat a cat.. If the charities agree that advance patients'time on earth are not worth the cost then they should state it honestly too as oppose to be highly patronising finishing their statement with "ask your doctor" it is painful to read.
Anyway does tyverk cost that much more than Herceptin? As well as Tyverk there is also the MAJOR ISSUE of cyber knife been disallowed.. we have seen that this operation has saved lives here with quite a few of us never recurring or many years later..
PS:Well done for writing to 2 MPs.
__________________
35 y/o
June 06: BC stage I
Grade 3; ER/PR neg
Her-2+++; lumpectomies
Aug 06: Stage IV
liver mets: 6 tumours
July 06 to Jan 07: 2*FEC+6*Taxotere; 3*TACE; LITT
March 07- Sept 07: Vaccination trial (phase 2, peptide based) at the UW (Seattle).
Herceptin since 2006
NED til Oct 09
Recurrence Oct 2009: to internal mammary gland since October 2009 missed on Oct and March 2010 scan.. palpable nodes in May 2010 when I realised..
Nov 2011:7 mets to lungs progressing fast failed hercp/tykerb/xeloda combo..
superior vena cava blocked: stent but face remains puffy
April 2012: Teresa Trial, randomised to TDM1
Nov 2012 progressing on TDM1
Dec 2012 blockage of my airways by tumours, obliteration of these blocking tumours breathing better but hoping for more- at mo too many tumours to count in the lungs and nodes.
Dec 2012 Starting new trial S-222611 phase 1b dual egfr her2+ inhibitor.
'Under no circumstances should you lose hope..' Dalai Lama
|
|
|
03-13-2009, 12:58 PM
|
#16
|
Senior Member
Join Date: Nov 2005
Location: Ireland
Posts: 3,463
|
Fullofbeans,
I was shocked at this. I'm quite close to you in Ireland and we've had Tykerb here also for the past couple of years. One of the ladies from the site here was able to avail of it when she moved here from Scotland. I think you need to certainly get some support from other cancer survivors/patients in the UK.
I don't have much in terms of practical advice but do have a suggestion. I post infrequently on a UK site which is quite busy,it's for all cancer's not just breast cancer. You may be able to drum up some support from other's there as there are quite a few breast cancer patients currently posting. The link is below-
www.cancerbuddiesnetwork.org
(I'm sure thats the correct link but if you have problems just contact me and I'll send on to you)..
__________________
Tricia
Dx July '05 IDC 1.9cm Triple positive 3/9 nodes positive
A/C X 4 ..Taxol/Herceptin x 12 wks then herceptin 1 yr
Rads x 36 ..oophorectomy August '06
Currently taking Arimidex..
June 2011 osteopenia/ zometa x1 yearly- stopped Zometa 2015 as Dexa show normal bone density.
Stopped Arimidex July 2014- Restarted Arimidex 2015 for a further two years on the advice of my Onc.
2014 Normal Dexa scan
2018 Mammo all clear, still NED!
|
|
|
03-13-2009, 12:58 PM
|
#17
|
Senior Member
Join Date: Feb 2009
Posts: 1,526
|
Hi all,contacted GSK amd eventually found someone who told me that the decision to appeal was still under consideration but a decision due soon. I understand that the cost of Tykerb is comparable to herceptin but does not need to be administered IV so there is a staff cost saving.
Regarding the cyberknife issue I understand from an MP that it is acknowledged that it is beneficial but they don,t want the capital outlay for each machine (told approx £70 million each).It feels like this is a similar issue to that of PET scanners which are not routinely used here and indeed NICE have stated should not be used in the metastatic setting.
BC is hard enough to face as everyone here knows-no wonder there is a prevailing sense of doom here when t so called experts tell us we're not worth the money. Ellie
|
|
|
03-13-2009, 01:10 PM
|
#18
|
Senior Member
Join Date: Jun 2007
Posts: 216
|
Hi all,
sorry about my rant last night. I am now going to contact as many mp's as I can to get it raised in parliament. As I said I was furious but it was no good saying that without getting motivated and doing something about it, which I am now with my husband to help .
I am also angry about the cancer charities pathetic response and also about cyberknife.
Being on this site makes you knowledgeable and I am fed up with the doctors in this country thinking they are God, they do not appreciate people like us finding out the facts before we go to see them, we often know more than they do, at least here in the uk.
Janie
|
|
|
03-13-2009, 01:37 PM
|
#19
|
Senior Member
Join Date: Feb 2009
Posts: 1,526
|
Well said Janie. I didn't read Tricia's post properly and have just read that it's available in Ireland and ? Scotland. For goodness sake how can this be right. Glad you are contacting your MP's,the more the better.I intend to get friends in other parts of England to do this as well.Ellie
|
|
|
03-13-2009, 04:20 PM
|
#20
|
Webmaster
Join Date: Feb 2005
Location: Home of the "Flying Tomato"
Carlsbad, CA
Posts: 2,036
|
This was posted on the Herceptin/Tykerb Board:
One view of what NICE is, and how it decides in the UK
I thought it might be helpful to post an overview for those not familiar with what happens in the UK regarding the National Institute for Health and Clinical Excellence (NICE) and how it comes to its decisions.
Bear in mind that I am no expert in these matters, just an interested bystander whose 'other half' has been through what many of you here have been through with HER2 BC. I have pulled together these comments from what I have found during my searching the internet. I believe what I say here is reasonably accurate but feel free to correct me if you know better (and I'm sure some of you will).
NICE is the independent organisation responsible for providing national guidance on the promotion of good health and the prevention and treatment of ill health, at least this is what it says on their website. It is not always publicly viewed as independent of the government by many people who feel that they are under pressure to meet costs first and decide on treatment second.
NICE uses a Quality Adjusted Life Year (QALY) to asses how a treatment measures up and if it is over a certain threshold, currently £20,000 ($28,000 US) it will go out for appeal on whether or not to proceed, if it is over £30,000 ($42,000 US) it normally says an outright NO.
One interpretation of QALY would be how much lifespan a person would be prepared to give up to deliver one year of perfect health from the current state of ill health. By comparing QALY values before and after treatment one could calculate the benefit delivered by a given treatment to a given person.
The cost of a treatment may be relatively easy to calculate but because people may be at different ages when they receive treatment, the gain may be different according to age. A heart operation on a small child may deliver many more years of quality of life than the same operation on a 76 year old man. By taking the cost of treatment and dividing it by the years gained an overall cost benefit ratio can be determined as the 'cost per quality-adjusted life year gained' or CQG.
NICE has pledged to speed up its appraisal process so that guidance is ready between three and six months after a drug is licensed. Currently the process can take up to two years.
Nice uses independent expert committees to evaluate new drugs for use on the NHS and they use a complicated calculation balancing the cost of the drug against how effective it is at improving length and quality of life.
The calculation arrives at an additional cost per "quality-adjusted life year" over and above
the price of existing treatments and if that figure is more than £30,000 then the drug is
generally not approved for use.
But the new rules will allow this level to be breached after a public consultation found most
people agreed that greater weight should be given to drugs that provide extra months of life for terminally ill patients.
It must be remembered that all of this is done for all drugs and the NHS budget has to cover all treatments not just cancer.
Now specifically there have been two recent decisions by NICE which have been brought up on this forum.
Firstly the Tykerb (often known as Tyverb in the UK) where they have come up with what is called a Final appraisal determination (PDF document) which can be read here.
You can see more comments on this here and here. Basically this document says that NICE is going to say NO to Tykerb. This can be appealed but is going to need a lot of people supporting this but I think it will need evidence as well as numbers.
Secondly the new Advanced breast cancer: diagnosis and treatment clinical guidelines which was published in February 2009. This is the document which says that Herceptin will be withdrawn from patients with advanced breast cancer. There are two sets of documents one for health professionals and another for patients both of which can be found here.
Both of these decisions mean that it unlikely that any NHS Hospital in the UK will consider giving either Tykerb or Herceptin for advanced breast cancer in future.
__________________
A Proud webmaster to the internet's most informed, educated, COMPASSIONATE and caring group of breast cancer survivors.
Illegitimi non carborundum
My Album
|
|
|
Posting Rules
|
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
HTML code is Off
|
|
|
All times are GMT -7. The time now is 02:20 PM.
|